top of page
Im Labor


Forschungszentrum für Tumor-Mikromilieu und Immunsystem Interaktionen

"At CCS we aim to understand the molecular and cellular interactions between cancer cells, the tumor microenvironment and the immune system"

CCS brings together 20 research groups in basic, translational and clinical cancer research from the Salzburg Cancer Research Institute (SCRI), the Paris-Lodron University of Salzburg (PLUS) and the Paracelsus Medical University Clinic Salzburg (SALK/PMU).

At CCS scientists focus on tumor-microenvironment interactions, the immune system and cancer stem cells to explore new cancer-driving mechanisms and develop  treatments with improved therapeutic efficacy.

bottom of page